Kodeinsirup Mit Eucalyptolgeschmack Conforma (Codeine)

Codeine is an opioid antitussive and analgesic used in the respiratory and pain‑management pathways.

• Cough: Reduces frequency and intensity of acute or chronic cough by suppressing the cough reflex.
• Mild to moderate pain: Provides analgesia for conditions such as dental pain, musculoskeletal discomfort, and postoperative pain.
• Bronchitis‑related cough: Helps control cough associated with bronchitis, improving patient comfort.

• Codeine acts as an agonist at µ‑opioid receptors in the central nervous system. Activation of these receptors diminishes the transmission of pain signals and depresses the cough center in the medulla, leading to reduced perception of pain and suppression of the cough reflex.

Codeine may cause a range of adverse reactions, which are grouped by frequency.

Common Side Effects

• Drowsiness: Feeling of sleepiness or reduced alertness.
• Constipation: Decreased bowel movements and hard stools.
• Nausea: Sensation of unease in the stomach, sometimes leading to vomiting.
• Dry mouth: Reduced salivation causing a parched feeling.

Serious or Rare Side Effects

• Respiratory depression: Slowed breathing that can be life‑threatening.
• Severe allergic reaction: Symptoms such as rash, swelling, or anaphylaxis.
• Dependence or addiction: Potential for misuse with prolonged use.
• Confusion or hallucinations: Altered mental status, especially at higher doses.

When prescribing or dispensing Codeine‑containing syrup, consider the following safety measures.

• Pregnancy: Use only if clearly needed, as safety data are limited.
• Breathing disorders: Caution in patients with asthma or COPD due to risk of respiratory depression.
• Concomitant CNS depressants: Avoid or monitor for additive sedation.
• History of substance abuse: Assess risk of dependence before initiating therapy.
• Store at ambient temperature: Keep below 25 °C, in the original container, protected from moisture and light.

Codeine can interact with several drug classes, requiring attention to avoid harmful effects.

Major Interactions (Avoid)

• Other opioids: Additive risk of respiratory depression and sedation.
• Benzodiazepines or barbiturates: Increased central nervous system depression.
• MAO inhibitors: May precipitate severe hypotension or serotonin syndrome.
• Alcohol: Potentiates sedative effects and respiratory depression.

Moderate Interactions (Monitor Closely)

• CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): May increase codeine plasma levels.
• Anticholinergic agents: May worsen constipation.
• Diuretics: May enhance hypotensive effect.